EnlivenHealth® and Good Neighbor Pharmacy® Seek to Empower Independent Pharmacies with New Clinical Scope of Practice and Reimbursement Solution

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. GOOGL
6. APGE
7. DFTX
8. MU
9. IBM
10. HOOD

Go back to EnlivenHealth® and Good Neighbor Pharmacy® Seek to Empower Independent Pharmacies with New Clinical Scope of Practice and Reimbursement Solution

Omnicell (OMCL) PT Raised to $61 at Piper Sandler

August 5, 2024 4:02 PM EDT

Piper Sandler analyst Sean Wieland raised the price target on Omnicell (NASDAQ: OMCL) to $61.00 (from $40.00) while maintaining a Overweight rating.

The analyst comments "The numbers. 2Q24 revenue of $276.8M came in $16.8M above the high end of guidance, owing to outperformance across both... More